Intuitive Surgical (NASDAQ:ISRG – Free Report) had its target price increased by UBS Group from $500.00 to $560.00 in a research report sent to investors on Monday. They currently have a neutral rating on the medical equipment provider’s stock.
A number of other research analysts have also issued reports on ISRG. Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday. Robert W. Baird lifted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Bernstein Bank boosted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday. Finally, Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.
Check Out Our Latest Research Report on ISRG
Intuitive Surgical Stock Performance
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,843 shares of company stock valued at $15,357,560. Corporate insiders own 0.90% of the company’s stock.
Institutional Investors Weigh In On Intuitive Surgical
Several hedge funds and other institutional investors have recently bought and sold shares of ISRG. Mirador Capital Partners LP increased its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares during the last quarter. M.E. Allison & CO. Inc. purchased a new position in Intuitive Surgical in the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical during the fourth quarter worth $82,517,000. Exome Asset Management LLC raised its position in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, Consolidated Planning Corp lifted its stake in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- What is the NASDAQ Stock Exchange?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Steel Stocks Soaring After Tariff Announcements
- The Basics of Support and Resistance
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.